These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30607129)

  • 1. Developing a model of a patient-group pathway to accessing cancer clinical trials in Canada.
    Batist G; Michaud S; Richards DP; Servidio-Italiano F; Stein BD
    Curr Oncol; 2018 Dec; 25(6):e597-e609. PubMed ID: 30607129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient and Patient Group Engagement in Cancer Clinical Trials: A Stakeholder Charter.
    Michaud S; Needham J; Sundquist S; Johnson D; Hanna S; Hosseinzadeh S; Bartekian V; Steele P; Benchimol S; Ross N; Stein BD
    Curr Oncol; 2021 Apr; 28(2):1447-1458. PubMed ID: 33917947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-Envisioning the Canadian Nephrology Trials Network: A Can-SOLVE-CKD Stakeholder Meeting of Patient Partners and Researchers.
    Murdoch A; Tennankore KK; Bohm C; Clase CM; Levin A; Vorster H; Suri RS
    Can J Kidney Health Dis; 2021; 8():20543581211030396. PubMed ID: 34345433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Rules of Engagement: CTTI Recommendations for Successful Collaborations Between Sponsors and Patient Groups Around Clinical Trials.
    Bloom D; Beetsch J; Harker M; Hesterlee S; Moreira P; Patrick-Lake B; Selig W; Sherman J; Smith SK; Valentine JE; Roberts JN
    Ther Innov Regul Sci; 2018 Mar; 52(2):206-213. PubMed ID: 29714514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canadian Contraception Consensus (Part 2 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
    J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration.
    Chan K; Nam S; Evans B; de Oliveira C; Chambers A; Gavura S; Hoch J; Mercer RE; Dai WF; Beca J; Tadrous M; Isaranuwatchai W
    BMJ Open; 2020 Jan; 10(1):e032884. PubMed ID: 31915169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian Contraception Consensus (Part 1 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
    J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process.
    Witham MD; Anderson E; Carroll C; Dark PM; Down K; Hall AS; Knee J; Maier RH; Mountain GA; Nestor G; Oliva L; Prowse SR; Tortice A; Wason J; Rochester L;
    Trials; 2020 Aug; 21(1):694. PubMed ID: 32738919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials recruitment planning: A proposed framework from the Clinical Trials Transformation Initiative.
    Huang GD; Bull J; Johnston McKee K; Mahon E; Harper B; Roberts JN;
    Contemp Clin Trials; 2018 Mar; 66():74-79. PubMed ID: 29330082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-Oriented Research Competencies in Health (PORCH) for patients, healthcare providers, decision-makers and researchers: protocol of a scoping review.
    Mallidou AA; Frisch N; Doyle-Waters MM; MacLeod MLP; Ward J; Atherton P
    Syst Rev; 2018 Jul; 7(1):101. PubMed ID: 30025543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adapting two American Decision Aids for Mild Traumatic Brain Injury to the Canadian Context Using the Nominal Group Technique.
    Ghandour EK; Lelaidier Hould L; Fortier FA; Gélinas V; Melnick ER; Hess EP; Lang ES; Gravel J; Perry JJ; Le Sage N; Truchon C; LeBlanc A; Dubrovsky AS; Gagnon MP; Ouellet MC; Gagnon I; McKenna S; Légaré F; Sauvé L; van de Belt TH; Kavanagh É; Paquette L; Verrette AC; Plante P; Riopelle RJ; Archambault PM;
    Patient; 2020 Dec; 13(6):729-743. PubMed ID: 33078377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing clinical evidence by proactively building quality into clinical trials.
    Meeker-O'Connell A; Glessner C; Behm M; Mulinde J; Roach N; Sweeney F; Tenaerts P; Landray MJ
    Clin Trials; 2016 Aug; 13(4):439-44. PubMed ID: 27098014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative.
    Calis KA; Archdeacon P; Bain R; DeMets D; Donohue M; Elzarrad MK; Forrest A; McEachern J; Pencina MJ; Perlmutter J; Lewis RJ
    Clin Trials; 2017 Aug; 14(4):342-348. PubMed ID: 28503947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of real-world evidence in cancer drug funding decisions in Canada: a qualitative study of stakeholders' perspectives.
    Clausen M; Mighton C; Kiflen R; Sebastian A; Dai WF; Mercer RE; Beca JM; Isaranuwatchai W; Chan KKW; Bombard Y
    CMAJ Open; 2020; 8(4):E772-E778. PubMed ID: 33234584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-World Data for Planning Eligibility Criteria and Enhancing Recruitment: Recommendations from the Clinical Trials Transformation Initiative.
    Evans SR; Paraoan D; Perlmutter J; Raman SR; Sheehan JJ; Hallinan ZP
    Ther Innov Regul Sci; 2021 May; 55(3):545-552. PubMed ID: 33393014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.